Tumour necrosis factor-alpha gene therapy
Latest Information Update: 20 Jul 1998
At a glance
- Originator Sapporo Medical University
- Class Antineoplastics; Cytokine genes; Gene therapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer